Testing a new spray in a malaria-prevention program
Part of Infections clinical trials.
This study looks at whether adding a special device (the Guardian Spatial Emanator) to the AZVINIR II azithromycin program helps prevent malaria. It involves checking households and health centers in high-malaria areas in Africa.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your household is in a health center area that is part of a large azithromycin treatment program (called AVENIR II).
- You live in an area with high malaria rates.
- Your household has been randomly picked to be in the study.
- The head of your household says it is okay for the study team to visit and do activities.
- The local health center chief says it is okay for the health center to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a mosquito repellent that is placed in homes to see if it helps prevent malaria. It is for children living in the area.
This study tests a new long-acting malaria prevention injection (MMV371) in healthy adults and adolescents in Rwanda. Researchers will monitor how safe it is and how your body processes it over 24 weeks.
This trial is testing a special device that releases a scent to repel mosquitoes, aiming to reduce malaria in young children in Uganda. If you have a child under 5 and are willing to use the device in your home, this study could help protect your child from malaria.
This Phase 3 trial tests whether giving malaria medicine to people in high-risk households (a “mass drug administration” campaign) can stop local relapses and eliminate vivax malaria. If you live close to a recent malaria case, you may be offered a preventive dose, based on age and medical safety checks.
This study compares two experimental malaria vaccines to see how safe they are and how well they protect adults. It may help future malaria prevention, and you would be closely monitored, including a malaria “challenge” test if you qualify.
This study tests a new pill called lotilaner for safety and how well it works to kill mosquitoes that carry malaria. It is for healthy adults in Mali and may help future malaria prevention efforts.
Hear when a new Malaria trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.